Population Pharmacokinetics of Volasertib Administered in Patients with Acute Myeloid Leukaemia as a Single Agent or in Combination with Cytarabine
Crossref DOI link: https://doi.org/10.1007/s40262-017-0566-9
Published Online: 2017-06-19
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
P. Solans, Belén
Fleury, Angèle
Freiwald, Matthias
Fritsch, Holger
Haug, Karin
Trocóniz, Iñaki F. http://orcid.org/0000-0003-3700-8658
Funding for this research was provided by:
Boehringer Ingelheim
License valid from 2017-06-19